Remdesivir is not suggested for patients admitted to hospital with covid-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival or the need for ventilation, say a @WHO Guideline Development Group panel https://t.co/a55cB9wuH9

— The BMJ (@bmj_latest) November 20, 2020